Poster Abstract Session:
42. ART: Efficacy and Resistance
Thursday, October 3, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C

Tracks: HIV-STD-TB

Presentations:

169
Comparison of Wild Type with Four Multi-Drug Resistant HIV-1 Protease Enzymes Utilizing Molecular Dynamics Simulation Techniques
Poorvi Chordia, M.D. ; Tamaria Dewdney ; Rodger Macarthur, M.D. ; Salimnia Hossein, Ph.D. ; Ladislau Kovari, Ph.D.

170
Antiretroviral Activity and Safety of Once-daily Etravirine in Treatment-na´ve HIV-infected Adults
Michelle Floris-Moore, MD, MS ; Katie Mollan, MS ; Aimee Wilkin, MD, MPH ; Marc Johnson, MD ; Angela Kashuba, BScPhm, PharmD, DABCP ; David Alain Wohl, MD ; Kristine Patterson, MD ; David Ragan, RN, BSN ; Clara Zelasky, PA ; David Currin, RN ; Donna Pittard, RN, BSN ; Joseph Eron, Jr., MD

171
Use of co-receptor tropism assay in an outpatient NYC HIV clinic
Matthew Mccarthy, MD ; Timothy Wilkin, MD/MPH ; Jonathan Genzen, MD/PhD ; Harjot Singh, MD/ScM

172
Safety and Efficacy of Dolutegravir (DTG; GSK1349572) in Treatment-Experienced HIV-1 Infected Adolescents: 24-Week Results from IMPAACT P1093
Rolando M. Viani, M.D. ; Nan Zheng ; Carmelita Alvero ; Rohan Hazra ; Ellen Townley O'gara ; Liz Petzold ; Barbara Heckman ; Debra Steimers ; Sherene Min ; Andrew Wiznia, MD

173
Posters
  • 173IDWPOSTER.pdf (682.7 kB)

  • 174
    Skin Rash Related to Once-daily Boosted Darunavir-Containing Regimen in HIV-infected Patients: Incidence and Associated Factor
    Kuan-Yin Lin, MD ; Chia-Jui Yang, MD ; Mao-Song Tsai, MD ; Szu-Min Hsieh, MD ; Wang-Huei Sheng, MD, PhD ; Sui-Yuan Chang, DSc ; Chien-Ching Hung, MD, MIH, PhD ; Shan-Chwen Chang, MD, PhD

    CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.